Log in to your Inderes Free account to see all free content on this page.
Initiator Pharma
3.39 SEK
-0.59 %
Less than 1K followers
INIT
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Initiator Pharma
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| growth-% | |||||||
| EBITDA | -13.0 | -14.2 | -31.8 | -62.7 | -40.4 | -22.3 | - |
| EBIT | -13.1 | -14.3 | -31.8 | -62.7 | -40.4 | -22.3 | -25.7 |
| Profit before taxes | -14.0 | -13.9 | -33.4 | -66.3 | -41.4 | -22.8 | -24.1 |
| Net income | -11.6 | -11.8 | -29.0 | -57.8 | -34.2 | -19.9 | -19.8 |
| EPS | -0.46 | -0.40 | -0.66 | -1.10 | -0.66 | -0.35 | -0.29 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % |
Login required
This content is only available for logged in users
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | |||||||
| EBIT-% | |||||||
| ROE | -83.6 % | -60.4 % | -60.2 % | -113.1 % | -204.9 % | -87.5 % | -46.3 % |
| ROI | -72.5 % | -55.7 % | -39.2 % | -81.0 % | -76.8 % | -84.6 % | -41.5 % |
Login required
This content is only available for logged in users